Profilo
Justin McCue is currently Chief Technology Officer at TScan Therapeutics, Inc. since 2023.
Dr. McCue is also Chief Technology Officer & Senior Vice President at Akebia Therapeutics, Inc. starting in 2026.
Formerly, Dr. McCue was Chief Technology Officer at Avectas Ltd. from 2022 to 2023.
Dr. McCue was Vice President-Technical Operations at Repertoire Immune Medicines, Inc. from 2019 to 2022.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of California, Berkeley.
Posizioni attive di Justin McCue
| Società | Posizione | Inizio |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 04/12/2023 |
| AKEBIA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2026 |
Precedenti posizioni note di Justin McCue
| Società | Posizione | Fine |
|---|---|---|
Avectas Ltd.
Avectas Ltd. Miscellaneous Commercial ServicesCommercial Services Provides cellular biotechnology services | Direttore Tecnico/Scientifico/R&S | 01/12/2023 |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Direttore Tecnico/Scientifico/R&S | 01/07/2022 |
Formazione di Justin McCue
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Avectas Ltd.
Avectas Ltd. Miscellaneous Commercial ServicesCommercial Services Provides cellular biotechnology services | Commercial Services |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
















